The Enterprise Value as of June 2026 (TTM) for Armata Pharmaceuticals, Inc. (ARMP) is 647.19M

According to Armata Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 647.19M. This represents a change of 49.65% compared to the average of 432.46M of the last 4 quarters.

Armata Pharmaceuticals, Inc. (ARMP) Historical Enterprise Value (quarterly & annually)

How has ARMP Enterprise Value performed in the past?

The mean historical Enterprise Value of Armata Pharmaceuticals, Inc. over the last ten years is 121.55M. The current 647.19M Enterprise Value has changed 53.15% with respect to the historical average. Over the past ten years (40 quarters), ARMP's Enterprise Value was at its highest in in the March 2026 quarter at 742.99M. The Enterprise Value was at its lowest in in the December 2018 quarter at -7197132.72.

Armata Pharmaceuticals, Inc. (ARMP) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Armata Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Armata Pharmaceuticals, Inc. (ARMP) Average Enterprise Value

How has ARMP Enterprise Value performed in the past?

The current Enterprise Value of Armata Pharmaceuticals, Inc. (ARMP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Armata Pharmaceuticals, Inc. (ARMP) Enterprise Value vs. Peers

How is ARMP’s Enterprise Value compared to its peers?

Armata Pharmaceuticals, Inc.’s Enterprise Value is greater than Sangamo Therapeutics, Inc. (53.89M), greater than Insight Molecular Diagnostics Inc. (125.45M), greater than C4 Therapeutics, Inc. (320.20M), greater than Codexis, Inc. (254.06M), greater than OmniAb, Inc. (260.96M), greater than Genfit S.A. (513.33M), greater than Nuvectis Pharma, Inc. (258.96M), greater than Neonc Technologies Holdings, Inc. (95.18M), less than SELLAS Life Sciences Group, Inc. (1.01B), greater than Innate Pharma S.A. (141.16M),

Build a custom stock screener for Armata Pharmaceuticals, Inc. (ARMP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Armata Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Armata Pharmaceuticals, Inc. (ARMP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Armata Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.